AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

MAY 9, 2023

He is a diagnostic radiologist with Athens Radiology Associates, P.C. and former president of the Georgia Radiological Society , from which he received a Gold Medal in 2018. Vice President Don Yoo, MD, FACR Yoo is the director of nuclear medicine at the Miriam Hospital , Providence, R.I., in Athens, Ga.,

Nuclear Medicine 52

Nuclear Medicine Government Communication Hospital 52

The British Institute of Radiology

SEPTEMBER 11, 2023

I graduated with my radiography degree in 2018 and since then I’ve worked in a wide variety of departments, from plain film to nuclear medicine. There is often research aimed at improving and advancing the field of diagnostic imaging. I’m also passionate about education, research, and (of course) radiography.

Radiography 52

Radiography Radiograph Radiographer Radiographer 52

Imaging Technology

JUNE 29, 2023

by the Company and a collaborator at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 24 – 27, 2023. program in prostate cancer with the nuclear medicine community at the SNMMI 2023 Annual Meeting,” said David E. Blue Earth Diagnostics received U.S. 177Lu-rhPSMA-10.1

Clinic 98

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 98

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine. NorthStar continues to advance FibroScint, a novel fibrin-specific diagnostic imaging agent labeled with Tc-99m for SPECT imaging.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98